Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Baxter
US Army
Chinese Patent Office
AstraZeneca
Daiichi Sankyo

Generated: August 18, 2019

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)

Docket ➤ Sign Up Date Filed 2014-06-03
Court District Court, D. New Jersey Date Terminated 2016-08-01
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand Defendant Referred To Karen M. Williams
Parties AGILA SPECIALITIES INC.; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; GLENMARK GENERICS INC., USA; INNOPHARMA LICENSING LLC; MYLAN INC.; MYLAN INSTITUTIONAL LLC; MYLAN LABORATORIES LTD.; MYLAN PHARMACEUTICALS INC.; ONCO THERAPIES LIMITED; SAGENT PHARMACEUTICALS, INC.; SANDOZ INC.; SANDOZ INTERNATIONAL GMBH; TEVA PHARMACEUTICALS USA, INC.
Patents 4,659,516; 6,774,122; 7,456,160; 8,329,680; 8,466,139
Attorneys ARNOLD B. CALMANN; CAITLIN P. HOGAN; CAROLYN SUZANNE WALL; CHRISTINA LYNN SAVERIANO; CHRISTOPHER JOHN BUGGY; ERIC I. ABRAHAM; JOHN EDMUND FLAHERTY; MELISSA E. FLAX; MICHAEL CROSS; MICHAEL RATO; MICHELLE LELAND; RAVIN R. PATEL; RIADH QUADIR
Firms Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C.; Carella, Byrne, Cecchi, Olstein, Brody & Agnello, PC; Christina Lynn Saveriano; Eric I. Abraham; Foley & Lardner LLP; McCarter and English, LLP; McElroy, Deutsch, Mulvaney & Carpenter; O'Melveny & Myers LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-06-03 1 THE PATENTS-IN-SUIT 17. United States Patent No. 6,774,122 (the “’122 patent”), entitled…to the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 31. Plaintiffs hereby reallege…INFRINGEMENT OF U.S. PATENT NO. 6,774,122 42. Plaintiffs hereby reallege…12. This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
2016-03-30 194 ORDER, Covenant Not to Sue Regarding U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. Signed…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. External link to document
2016-06-20 261 admits that U.S. Patent No. 4,659,516 (“the ’516 patent”) was assigned to … Patent, the ’160 Patent, the ’680 Patent, and the ’139 Patent as the …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed …Sagent’s counterclaims as to the ’160 patent because that patent is no longer alleged to be infringed … ’122 patent, and that AstraZeneca UK Limited is the beneficial owner of the ’122 patent. AstraZeneca External link to document
2016-07-12 316 from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2014 1 August 2016 1:14-cv-03547 830 Patent Defendant District Court, D. External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Citi
Medtronic
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.